{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T04:17:18Z","timestamp":1781497038079,"version":"3.54.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T00:00:00Z","timestamp":1722816000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["PR-PRU-1217-20901"],"award-info":[{"award-number":["PR-PRU-1217-20901"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","valueinhealthjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jval.2024.07.014","type":"journal-article","created":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T05:29:10Z","timestamp":1722576550000},"page":"1479-1487","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Assessing the Health and Welfare Benefits of Interventions Using the Wider Societal Impacts Framework"],"prefix":"10.1016","volume":"27","author":[{"given":"Shainur","family":"Premji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jval.2024.07.014_bib1","series-title":"The Economics of the Welfare State","author":"Barr","year":"1998"},{"key":"10.1016\/j.jval.2024.07.014_bib2","series-title":"Principles of Macroeconomics","author":"Mankiw","year":"2006"},{"key":"10.1016\/j.jval.2024.07.014_bib3","series-title":"Methods for the Economic Evaluation of Health Care Programmes","author":"Drummond","year":"2015"},{"issue":"1","key":"10.1016\/j.jval.2024.07.014_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hec.3130","article-title":"Causes for concern: is NICE failing to uphold its responsibilities to all NHS patients?","volume":"24","author":"Claxton","year":"2015","journal-title":"Health Econ"},{"issue":"2","key":"10.1016\/j.jval.2024.07.014_bib7","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jval.2016.12.005","article-title":"Toward a broader concept of value: identifying and defining elements for an expanded cost-effectiveness analysis","volume":"20","author":"Garrison","year":"2017","journal-title":"Value Health"},{"issue":"5","key":"10.1016\/j.jval.2024.07.014_bib8","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/hec.850","article-title":"Should the consumption of survivors be included as a cost in cost\u2013utility analysis?","volume":"13","author":"Nyman","year":"2004","journal-title":"Health Econ"},{"issue":"8","key":"10.1016\/j.jval.2024.07.014_bib9","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s10198-014-0618-0","article-title":"Considering productivity loss in cost-effectiveness analysis: a new approach","volume":"15","author":"Gandjour","year":"2014","journal-title":"Eur J Health Econ"},{"issue":"2","key":"10.1016\/j.jval.2024.07.014_bib11","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jhealeco.2007.07.003","article-title":"Welfarism vs. extra-welfarism","volume":"27","author":"Brouwer","year":"2008","journal-title":"J\u00a0Health Econ"},{"issue":"4","key":"10.1016\/j.jval.2024.07.014_bib12","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0167-6296(99)00038-7","article-title":"On the economic foundations of CEA. Ladies and gentlemen, take your positions","volume":"19","author":"Brouwer","year":"2000","journal-title":"J\u00a0Health Econ"},{"issue":"9","key":"10.1016\/j.jval.2024.07.014_bib13","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s40273-023-01275-6","article-title":"Accounting for nonhealth and future costs in cost-effectiveness analysis: distributional impacts of a US cancer prevention strategy","volume":"41","author":"Kim","year":"2023","journal-title":"Pharmacoeconomics"},{"issue":"4","key":"10.1016\/j.jval.2024.07.014_bib14","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/hec.1181","article-title":"Unrelated medical care in life years gained and the cost utility of primary prevention: in search of a \u201cperfect\u201d cost-utility ratio","volume":"16","author":"Van Baal","year":"2007","journal-title":"Health Econ"},{"issue":"11","key":"10.1016\/j.jval.2024.07.014_bib15","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1016\/j.jval.2021.05.002","article-title":"Measurement instruments of productivity loss of paid and unpaid work: a systematic review and assessment of suitability for health economic evaluations from a societal perspective","volume":"24","author":"Hubens","year":"2021","journal-title":"Value Health"},{"issue":"5","key":"10.1016\/j.jval.2024.07.014_bib16","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s40258-019-00481-8","article-title":"Striving for a societal perspective: a framework for economic evaluations when costs and effects fall on multiple sectors and decision makers","volume":"17","author":"Walker","year":"2019","journal-title":"Appl Health Econ Health Policy"},{"issue":"3","key":"10.1016\/j.jval.2024.07.014_bib17","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s40258-023-00801-z","article-title":"The broader opportunity costs in the broader cost-effectiveness analysis framework","volume":"21","author":"Vallejo-Torres","year":"2023","journal-title":"Appl Health Econ Health Policy"},{"issue":"2","key":"10.1016\/j.jval.2024.07.014_bib18","first-page":"234","article-title":"Developing a value framework: the need to reflect the opportunity costs of funding decisions","volume":"20","author":"Sculpher","year":"2017"},{"key":"10.1016\/j.jval.2024.07.014_bib19","author":"Wailoo"},{"key":"10.1016\/j.jval.2024.07.014_bib20","author":"Roberts"},{"key":"10.1016\/j.jval.2024.07.014_bib21","author":"Griffin"},{"key":"10.1016\/j.jval.2024.07.014_bib22","author":"Miners"},{"key":"10.1016\/j.jval.2024.07.014_bib23","author":"Miners"},{"issue":"1","key":"10.1016\/j.jval.2024.07.014_bib27","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1146\/annurev.economics.102308.124436","article-title":"Health, human capital, and development","volume":"2","author":"Bleakley","year":"2010","journal-title":"Annu Rev Econ"},{"issue":"3","key":"10.1016\/j.jval.2024.07.014_bib28","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0168-8510(96)00815-9","article-title":"The willingness to pay for health changes, the human-capital approach and the external costs","volume":"36","author":"Johannesson","year":"1996","journal-title":"Health Policy"},{"issue":"5","key":"10.1016\/j.jval.2024.07.014_bib29","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/hec.4003","article-title":"Distributional cost effectiveness analysis of West Yorkshire low emission zone policies","volume":"29","author":"Griffin","year":"2020","journal-title":"Health Econ"},{"key":"10.1016\/j.jval.2024.07.014_bib30","author":"Premji"},{"key":"10.1016\/j.jval.2024.07.014_bib31","author":"Premji"},{"issue":"1","key":"10.1016\/j.jval.2024.07.014_bib34","article-title":"Catalog of EQ-5D-3L health-related quality-of-life scores for 199 chronic conditions and health risks in Denmark","volume":"8","author":"Hvidberg","year":"2023","journal-title":"MDM Policy Pract"},{"issue":"3","key":"10.1016\/j.jval.2024.07.014_bib35","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1177\/1536867X1501500307","article-title":"Fitting adjusted limited dependent variable mixture models to EQ-5D","volume":"15","author":"Alava","year":"2015","journal-title":"Stata J"},{"issue":"5","key":"10.1016\/j.jval.2024.07.014_bib36","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1524-4733.2005.00046.x","article-title":"The routine collation of health outcomes data from hospital treated subjects in the health outcomes data repository (HODaR): descriptive analysis from the first 20,000 subjects","volume":"8","author":"Currie","year":"2005","journal-title":"Value Health"},{"issue":"9","key":"10.1016\/j.jval.2024.07.014_bib37","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s40273-023-01307-1","article-title":"Moving forward with taking a societal perspective: a themed issue on productivity costs, consumption costs and informal care costs","volume":"41","author":"Brouwer","year":"2023","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jval.2024.07.014_bib38","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/hec.3138","article-title":"Future costs, fixed healthcare budgets, and the decision rules of CEA","volume":"25","author":"Van Baal","year":"2016","journal-title":"Health Econ"},{"issue":"1","key":"10.1016\/j.jval.2024.07.014_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10198-018-0976-0","article-title":"Future unrelated medical costs need to be considered in cost effectiveness analysis","volume":"20","author":"Van Baal","year":"2019","journal-title":"Eur J Health Econ"},{"issue":"9","key":"10.1016\/j.jval.2024.07.014_bib40","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s40273-023-01246-x","article-title":"Associating health-related quality-of-life score with time uses to inform productivity measures in cost-effectiveness analysis","volume":"41","author":"Jiao","year":"2023","journal-title":"Pharmacoeconomics"},{"issue":"14","key":"10.1016\/j.jval.2024.07.014_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta19140","article-title":"Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold","volume":"19","author":"Claxton","year":"2015","journal-title":"Health Technol Assess"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301524027979?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301524027979?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T12:59:34Z","timestamp":1778590774000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301524027979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1098301524027979"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2024.07.014","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing the Health and Welfare Benefits of Interventions Using the Wider Societal Impacts Framework","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2024.07.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society for Pharmacoeconomics and Outcomes Research, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}